GIST rectal sincrónico a adenocarcinoma de colonuna asociación inusual

  1. M Alcaide Lucena 1
  2. J Rubio López 2
  3. MÁ García Martínez 1
  4. MS Zurita Saavedra 1
  5. P de Castro Monedero 1
  6. B Mirón Pozo 1
  7. Cristina González Callejas
  1. 1 Hospital Universitario San Cecilio. Granada.
  2. 2 Complejo Hospitalario de Jaén. Jaén.
Journal:
Cirugía Andaluza

ISSN: 2695-3811,  1130-3212

Year of publication: 2019

Issue Title: XVI Congreso de la ASAC (2019, Sevilla)

Volume: 30

Issue: 3

Pages: 419-422

Type: Article

DOI: 10.37351/2019303.24 DIALNET GOOGLE SCHOLAR lock_openDialnet editor

More publications in: Cirugía Andaluza

Sustainable development goals

Abstract

About 13-20% of patients with gastrointestinal stromal tumors (GIST) present a synchronic or metachronic secondary tumor, typically in the gastrointestinal tract. We present a case of an 81 year-old man with rectorrhagia and proctalgia diagnosed by colonoscopy and biopsy, with sigmoid adenocarcinoma synchronic to a rectal GIST. Treatment combined low anterior resection with endoanal resection of the rectal lession. The importance of this case lays in the low frequency of rectal GIST (7-11%) and the even lower frequency of synchronic association with a colorectal adenocarcinoma.

Bibliographic References

  • Errasti J.Espín E and Reina Á. Neoplasias de recto poco frecuentes. Revisión de conjunto. Cir Esp 2014 ; 92: 579-588.
  • The ESMO European Sarcoma Network Working Group. Gastrointestinal stromal tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012; 23: 49–55.
  • Katz SC, DeMatteo RP. Gastrointestinal stromal tumors and leiomyosarcomas. J Surg Oncol. 2008; 97: 350–9.
  • Gaitanidis A, El Lakis M, Alevizakos M, Tsaroucha A, Pitiakoudis M. Predictors of lymph node metastasis in patients with gastrointestinal stromal tumors (GISTs). Langenbecks Arch Surg. 2018; 403(5):599-606.
  • Kubo N, Takeuchi N. Gastrointestinal stromal tumor of the stomach with axillary lymph node metastasis: A case report. World J 2017; 23(9):1720.
  • Joensuu H, Vehtari A, Riihimaki T, Steigen SE, Plank L, Nilsson B, et al. Risk of recurrence of gastrointestinal stromal tumour after surgery: An analysis of pooled population-based cohorts. Lancet Oncol. 2012; 13:265–74.
  • DeMatteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, et al. Adjuvant imatinib mesylate after resection of localized, primary gastrointestinal stromal tumour: A randomized, dobleblind, placebo-controlled trial. Lancet. 2009; 373:1097–104.
  • Gonçalves R, Linhares E, Albagli R, Valadão M, Vilhena B, Romano S. and Ferreira C. Occurrence of other tumors in patients with GIST. Surg Oncol 2010; 19:140-143.
  • Wronski M. Synchronous occurrence of gastrointestinal stromal tumors and other primary gastrointestinal neoplasms. World J Gastroenterol 2006 12: 5360.
  • Liszka Ł, Zielińska-Pająk E, Pająk J, Gołka D and Huszno Coexistence of gastrointestinal stromal tumors with other neoplasms. Journal Gastroenterol 2006; 42: 641-649.
  • Agaimy A, Wünsch P, Sobin L, Lasota J and Miettinen M. Occurrence of other malignancies in patients with gastrointestinal stromal tumors. Seminars in Diagnostic Pathology 2006; 23: 120-129.
Data source: Dialnet